Table 1.
CBT-i (N=41) | Control (N=100) | p | |
---|---|---|---|
Mean age, years (SD) | 51.80 (14.62) | 52.12 (14.04) | 0.90 |
Sex, male/female | 10/31 | 26/74 | 0.84 |
Patients with psychiatric comorbidities, N (%) | 7 (17) | 13 (13) | 0.33 |
Patients with medical comorbidities, N (%) | 13* (31) | 34† (34) | 0.80 |
Patients with cancer, N (%) | 4‡ (10) | 10§ (10) | 0.97 |
Mean duration of total follow-up, days (SD) | 541.85 (694.95) | 610.09 (643.33) | 0.58 |
hypertension (N=3), diabetes mellitus (N=2), chronic heart failure (N=1), destroyed lung due to old pulmonary tuberculosis (N=1), cancer (N=4),
hypertension (N=8), diabetes mellitus (N=3), coronary artery disease (N=3), end stage renal disease (N=2), migraine (N=2), asthma (N=1), herniated cervical disc (N=1), osteoporosis (N=1), hyperthyroidism (N=1), aneurysm (N=1), cancer (N=10),
breast cancer (N=2), thyroid cancer (N=1), acute myeloblastic leukemia (N=1),
breast cancer (N=6), advanced gastric cancer (N=2), thyroid cancer (N=1), sigmoid colon cancer (N=1).
CBT-i: cognitive behavioral therapy of insomnia, SD: standard deviation